# Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease

> **NCT02242032** · PHASE1 · COMPLETED · sponsor: **Parion Sciences** · enrollment: 53 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** P-321 Ophthalmic Solution
- **DRUG:** P-321 Ophthalmic Solution placebo

## Key facts

- **NCT ID:** NCT02242032
- **Lead sponsor:** Parion Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2015-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242032, "Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02242032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*